MYCN and neuroblastoma: Amplification of MYCN is associated with tumor initiation and progression, and occurs in ~20% of all neuroblastoma cases, with a higher incidence in INSS stages 3 and 4 compared to stages 1, 2, and 4S, suggesting a contribution in regulating oncogenic pathways3,12,13.